手术室内修复在缺血性心力衰竭治疗中仍然相关吗? 一个20年的随访研究
Huajun Zhang1,2, Changqing Gao1, Cangsong Xiao2
1Department of Cardiovascular Surgery, The First Medical Center of Chinese PLA General Hospital.
概括
手术腹腔复原 (SVR) 为患有缺血性心力衰竭的患者提供了优异的长期生存和改善心脏功能. 这种手术仍然是一个有价值的治疗选择,尽管医疗疗的进步.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 心脏衰竭治疗方法 治疗方法
背景情况:
- 缺血性心力衰竭是一个重大挑战,随着治疗选择的不断发展.
- 手术腹腔复原 (SVR) 的长期疗效需要持续评估.
- 评估SVR在新治疗技术中的作用至关重要.
研究的目的:
- 评估SVR.的长期外科和心声学结果.
- 确定患有缺血性心力衰竭的患者SVR20年术后结果.
- 为了澄清SVR在当代心力衰竭管理中的持续相关性.
主要方法:
- 一组128名患有缺血性心力衰竭的患者在1997年4月至2019年12月期间接受了SVR.
- 当需要时,同时进行了手术复血管化.
- 患者的随访时间长达20年,定期进行心声回声评估.
主要成果:
- 操作死亡率为3.1%.
- 手术后的左心室射出分数显著改善,缩小了末缩和末放缩体积.
- 五年,10年和20年的生存率分别为91.27%,75.76%和20.91%.
结论:
- SVR显示出优异的长期存活率.
- 该程序导致左心室功能显著改善.
- SVR仍然是缺血性心力衰竭的重要治疗选择.
相关概念视频
Cardiomyopathy V: Interprofessional Care
314
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Mitral Regurgitation III: Medical Management
257
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
257
Mitral Stenosis III: Medical Management
223
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Aortic Regurgitation III: Medical Management
375
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
375
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235


